
Chiesi’s Holoclar has become the first stem cell therapy to get the green light in Europe, gaining conditional approval from …

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

